Strategic GPO Consultants offers comprehensive GPO consulting and National Account services from value proposition development to GPO contract negotiation to post-contract commercialization and optimization.
Strategic GPO Consultants is highly recognized in the industry for comprehensive post-contract implementation and commercialization strategies that drive GPO contract uptake, compliance, and impactful revenue results.
With over 40 years of executive experience in medical devices, medtech business development, sales, and corporate strategy—ranging from Fortune 50 companies to emerging growth firms—Strategic GPO Consultants provides customized strategy consulting to CEOs of medtech companies seeking revenue growth, market expansion, and enhanced brand recognition.
Strategic GPO Consultants has delivered advisory services to emerging growth, small-cap, and mid-cap companies, leading to impactful strategic partnerships with Fortune 50 organizations. The firm has been recognized both nationally and internationally and has provided strategic advisory services to companies in the USA, Germany, France, China, Australia, Singapore, Canada, India, and Lithuania.
Strategic GPO Consultants received the Outstanding Organization Award at the Health 2.0 Conference held in Dubai, UAE. Health 2.0 is a premier international conference attended by over 2,000 trailblazing healthcare innovators, investors, strategics, and providers from 45 countries, including Siemens Healthineers, 3M, Mayo Clinic, Yale University School of Medicine, Saudi German Hospital Group, and RAK Hospital, UAE.
Strategic GPO Consultants offers strategic advisory services to Boards seeking guidance for critical market expansion needs. Dr. Sugintas has served on multiple boards in the health care industry, where she has provided transformational strategic advisory services on leading commercial business and marketing strategies.
Strategic GPO Consultants is highly experienced in commercialization and Go-To- Market (GTM) strategy consulting both to emerging growth and mid sized companies seeking to scale nationally, and to companies based internationally seeking commercialization and market expansion in the USA.
As an internationally acclaimed Healthcare and Commercial Medtech Subject Matter Expert, Dr. Nora Sugintas has provided invaluable insights to Private Equity, Venture Capital, and Consulting Firms.
Dr. Nora Sugintas has received numerous national and international recognitions including “Who’s Who in the Medicine and Healthcare”, “Who’s Who in the World”, and “Who’s Who in Business and Industry”. Dr. Sugintas was recently named Top 100 Healthcare Leader by the International Foundation on Advancements in Healthcare.
